|
1
|
Clouet J, Fusellier M, Camus A, Le Visage
C and Guicheux J: Intervertebral disc regeneration: From cell
therapy to the development of novel bioinspired endogenous repair
strategies. Adv Drug Deliv Rev. 146:306–324. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karran EL, McAuley JH, Traeger AC, Hillier
SL, Grabherr L, Russek LN and Moseley GL: Can screening instruments
accurately determine poor outcome risk in adults with recent onset
low back pain? A systematic review and meta-analysis. BMC Med.
15:132017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang WJ, Yu XH, Wang C, Yang W, He WS,
Zhang SJ, Yan YG and Zhang J: MMPs and ADAMTSs in intervertebral
disc degeneration. Clin Chim Acta. 448:238–246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Evangelatos G, Fragoulis GE, Koulouri V
and Lambrou GI: MicroRNAs in rheumatoid arthritis: From
pathogenesis to clinical impact. Autoimmun Rev. 18:1023912019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou X, Chen L, Grad S, Alini M, Pan H,
Yang D, Zhen W, Li Z, Huang S and Peng S: The roles and
perspectives of microRNAs as biomarkers for intervertebral disc
degeneration. J Tissue Eng Regen Med. 11:3481–3487. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Makki MS and Haqqi TM: MiR-139 modulates
MCPIP1/IL-6 expression and induces apoptosis in human OA
chondrocytes. Exp Mol Med. 47:e1892015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang Z, Pang G, Huang YG and Li C:
MiR-133 inhibits proliferation and promotes apoptosis by targeting
LASP1 in lupus nephritis. Exp Mol Pathol. 114:1043842020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Liu X, Sun B, Du W, Zheng Y and
Sun Y: Upregulated miR-154 promotes ECM degradation in
intervertebral disc degeneration. J Cell Biochem. 2019.(Epub ahead
of print).
|
|
10
|
Zhu W, Li L and Li D: Rs11655237
polymorphism of LINC00673 affects the prognosis of cervical cancer
by interfering with the interaction between LINC00673 and
microRNA-1231. J Cell Physiol. 235:8155–8166. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Majem B, Parrilla A, Jiménez C,
Suárez-Cabrera L, Barber M, Marín A, Castellví J, Tamayo G,
Moreno-Bueno G, Ponce J, et al: MicroRNA-654-5p suppresses ovarian
cancer development impacting on MYC, WNT and AKT pathways.
Oncogene. 38:6035–6050. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu M, Wang C, Chen W, Mao C and Wang J:
MiR-654-5p Targets GRAP to promote proliferation, metastasis, and
chemoresistance of oral squamous cell carcinoma through Ras/MAPK
Signaling. DNA Cell Biol. 37:381–388. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pu M, Chen J, Tao Z, Miao L, Qi X, Wang Y
and Ren J: Regulatory network of miRNA on its target: Coordination
between transcriptional and post-transcriptional regulation of gene
expression. Cell Mol Life Sci. 76:441–451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Zhang Y, Liu P, Bai H, Li X, Xiao
J, Yuan Q, Geng S, Yin H, Zhang H, et al: MicroRNA-128 knockout
inhibits the development of Alzheimer's disease by targeting PPARγ
in mouse models. Eur J Pharmacol. 843:134–144. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang H, Liao D, Tong L, Zhong L and Wu K:
MiR-373 exacerbates renal injury and fibrosis via
NF-κB/MatrixMetalloproteinase-9 signaling by targeting Sirtuin1.
Genomics. 111:786–792. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang W and Sun P: Downregulation of
microRNA-129-5p increases the risk of intervertebral disc
degeneration by promoting the apoptosis of nucleus pulposus cells
via targeting BMP2. J Cell Biochem. 120:19684–19690. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tan YY, Xu XY, Wang JF, Zhang CW and Zhang
SC: MiR-654-5p attenuates breast cancer progression by targeting
EPSTI1. Am J Cancer Res. 6:522–532. 2016.PubMed/NCBI
|
|
18
|
Pfirrmann CW, Metzdorf A, Zanetti M,
Hodler J and Boos N: Magnetic resonance classification of lumbar
intervertebral disc degeneration. Spine (Phila Pa 1976).
26:1873–1878. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
World Medical Association: World medical
association declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194. 2013.
View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hochberg Y and Benjamini Y: More powerful
procedures for multiple significance testing. Stat Med. 9:811–818.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng C, Liu H, Yang Y, Huang B and Zhou Y:
Growth and differentiation factor-5 contributes to the structural
and functional maintenance of the intervertebral disc. Cell Physiol
Biochem. 35:1–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng C, Liu H, Yang M, Zhang Y, Huang B
and Zhou Y: Disc cell senescence in intervertebral disc
degeneration: Causes and molecular pathways. Cell Cycle.
15:1674–1684. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li ZY, Wang XL, Dang Y, Zhu XZ, Zhang YH,
Cai BX and Zheng L: Long non-coding RNA UCA1 promotes the
progression of paclitaxel resistance in ovarian cancer by
regulating the miR-654-5p/SIK2 axis. Eur Rev Med Pharmacol Sci.
24:591–603. 2020.PubMed/NCBI
|
|
25
|
Le Maitre CL, Pockert A, Buttle DJ,
Freemont AJ and Hoyland JA: Matrix synthesis and degradation in
human intervertebral disc degeneration. Biochem Soc Trans.
35:652–655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vo NV, Hartman RA, Yurube T, Jacobs LJ,
Sowa GA and Kang JD: Expression and regulation of
metalloproteinases and their inhibitors in intervertebral disc
aging and degeneration. Spine J. 13:331–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lippai M and Szatmari Z: Autophagy-from
molecular mechanisms to clinical relevance. Cell Biol Toxicol.
33:145–168. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang W, Zhang X, Hao J, Shen J, Fang J,
Dong W, Wang D, Zhang X, Shui W, Luo Y, et al: SIRT1 protects
against apoptosis by promoting autophagy in degenerative human disc
nucleus pulposus cells. Sci Rep. 4:74562014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang XH, Zhu L, Hong X, Wang YT, Wang F,
Bao JP, Xie XH, Liu L and Wu XT: Resveratrol attenuated
TNF-α-induced MMP-3 expression in human nucleus pulposus cells by
activating autophagy via AMPK/SIRT1 signaling pathway. Exp Biol Med
(Maywood). 241:848–853. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu K, Chen W, Wang X, Peng Y, Liang A,
Huang D, Li C and Ye W: Autophagy attenuates the catabolic effect
during inflammatory conditions in nucleus pulposus cells, as
sustained by NF-κB and JNK inhibition. Int J Mol Med. 36:661–668.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Akkoc Y and Gozuacik D: MicroRNAs as major
regulators of the autophagy pathway. Biochim Biophys Acta Mol Cell
Res. 1867:1186622020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gaviraghi M, Vivori C, Pareja Sanchez Y,
Invernizzi F, Cattaneo A, Santoliquido BM, Frenquelli M, Segalla S,
Bachi A, Doglioni C, et al: Tumor suppressor PNRC1 blocks rRNA
maturation by recruiting the decapping complex to the nucleolus.
EMBO J. 37:e991792018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen DY, Chen YM, Lin CF, Lo CM, Liu HJ
and Liao TL: MicroRNA-889 inhibits autophagy to maintain
mycobacterial survival in patients with latent tuberculosis
infection by targeting TWEAK. mBio. 11:e03045–19. 2020. View Article : Google Scholar
|
|
34
|
Wang WJ, Yang W, Ouyang ZH, Xue JB, Li XL,
Zhang J, He WS, Chen WK, Yan YG and Wang C: MiR-21 promotes ECM
degradation through inhibiting autophagy via the PTEN/akt/mTOR
signaling pathway in human degenerated NP cells. Biomed
Pharmacother. 99:725–734. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiong J: Atg7 in development and disease:
Panacea or Pandora's Box? Protein Cell. 6:722–734. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu K, Li N, Cheng Q, Zheng J, Zhu M, Bao
S, Chen M and Shi G: MiR-96-5p prevents hepatic stellate cell
activation by inhibiting autophagy via ATG7. J Mol Med (Berl).
96:65–74. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang C, Zhang ZZ, Yang W, Ouyang ZH, Xue
JB, Li XL, Zhang J, Chen WK, Yan YG and Wang WJ: MiR-210
facilitates ECM degradation by suppressing autophagy via silencing
of ATG7 in human degenerated NP cells. Biomed Pharmacother.
93:470–479. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang H, Zhang X and Zhang J: MiR-129-5p
inhibits autophagy and apoptosis of H9c2 cells induced by hydrogen
peroxide via the PI3K/AKT/mTOR signaling pathway by targeting
ATG14. Biochem Biophys Res Commun. 506:272–277. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He W and Cheng Y: Inhibition of miR-20
promotes proliferation and autophagy in articular chondrocytes by
PI3K/AKT/mTOR signaling pathway. Biomed Pharmacother. 97:607–615.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang Y, Kwok-Shing Ng P, Kucherlapati M,
Chen F, Liu Y, Tsang YH, de Velasco G, Jeong KJ, Akbani R,
Hadjipanayis A, et al: A pan-cancer proteogenomic atlas of
PI3K/AKT/mTOR pathway alterations. Cancer Cell. 31:820–832.e3.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao D, Zhang S, Wang X, Gao D, Liu J, Cao
K, Chen L, Liu R, Liu J and Long J: ATG7 regulates hepatic Akt
phosphorylation through the c-JUN/PTEN pathway in high fat
diet-induced metabolic disorder. FASEB J. 33:14296–14306. 2019.
View Article : Google Scholar : PubMed/NCBI
|
